6/18
10:12 am
vxrt
Vaxart anticipates funds to extend its cash runway into 2026 [Seeking Alpha]
High
Report
Vaxart anticipates funds to extend its cash runway into 2026 [Seeking Alpha]
6/17
04:07 pm
vxrt
Vaxart Provides Business Update [Yahoo! Finance]
High
Report
Vaxart Provides Business Update [Yahoo! Finance]
6/17
04:05 pm
vxrt
Vaxart Provides Business Update
High
Report
Vaxart Provides Business Update
6/14
10:20 am
vxrt
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering [Yahoo! Finance]
High
Report
Vaxart Bags $453M Worth BARDA-Funded Project, Seeks To Raise $40M Via Equity Offering [Yahoo! Finance]
6/13
08:47 pm
vxrt
U.S. government to fund up to $500-million for studies on oral, nasal COVID vaccines [Globe and Mail, The (Toronto, Canada)]
High
Report
U.S. government to fund up to $500-million for studies on oral, nasal COVID vaccines [Globe and Mail, The (Toronto, Canada)]
6/13
07:13 pm
vxrt
Vaxart Announces $40 Million Underwritten Offering of Common Stock [Yahoo! Finance]
High
Report
Vaxart Announces $40 Million Underwritten Offering of Common Stock [Yahoo! Finance]
6/13
07:07 pm
vxrt
Vaxart Announces $40 Million Underwritten Offering of Common Stock
High
Report
Vaxart Announces $40 Million Underwritten Offering of Common Stock
6/13
06:39 pm
vxrt
US government to fund up to $500 million for studies on oral, nasal COVID vaccines [Yahoo! Finance]
High
Report
US government to fund up to $500 million for studies on oral, nasal COVID vaccines [Yahoo! Finance]
6/13
04:33 pm
vxrt
Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate [Yahoo! Finance]
High
Report
Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate [Yahoo! Finance]
6/13
04:15 pm
vxrt
Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
High
Report
Vaxart Receives BARDA-Funded Project NextGen Award Valued Up to $453 Million to Conduct a Phase 2b Study Evaluating Its COVID-19 Oral Pill Vaccine Candidate
5/23
04:05 pm
vxrt
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
5/23
04:01 pm
vxrt
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
5/13
04:11 pm
vxrt
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results [Yahoo! Finance]
Medium
Report
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results [Yahoo! Finance]
5/13
04:01 pm
vxrt
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
Medium
Report
Vaxart Provides Business Update and Reports First Quarter 2024 Financial Results
5/7
08:00 am
vxrt
Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13
Low
Report
Vaxart to Host First Quarter 2024 Business Update and Financial Results Conference Call on May 13
4/30
08:17 am
vxrt
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers [Yahoo! Finance]
Low
Report
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers [Yahoo! Finance]
4/30
08:00 am
vxrt
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
Medium
Report
Vaxart Announces Positive Results for Its Bivalent Norovirus Vaccine Candidate in Lactating Mothers
3/27
08:00 am
vxrt
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
Medium
Report
Vaxart to Present at World Vaccine Congress Washington 2024 on April 3
3/20
08:11 am
vxrt
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
Medium
Report
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
3/20
08:00 am
vxrt
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Vaxart, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)